PSEN1 and Alzheimer disease: Studies showed that familial AD PS1 (presenilin 1) mutations increased lysosomal alkalization and decreased lysosomal hydrolytic activity, thereby implicating compromised lysosomal function as a contributing factor in AD (Coffey et al., 2014).